FDA Clears Johnson & Johnson Hepatitis C Drug

By: AP Email
By: AP Email

WASHINGTON (AP) - Federal regulators have approved a new drug from Johnson & Johnson for use in treating chronic hepatitis C infections.

The U.S. Food and Drug Administration said Friday it approved the drug, a protease inhibitor that blocks a protein needed by the virus to replicate.

The Johnson & Johnson drug is designed to eliminate hepatitis C, the most common form of the liver-destroying virus. It is a daily pill taken in combination with the long-established drug cocktail used to treat the most common form of the virus.

The FDA's decision comes less than a month after an FDA advisory panel voted unanimously in favor of approving the treatment.

More than 3 million people in the U.S. have hepatitis C, a blood-borne disease that is blamed for 15,000 deaths a year.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KOLO-TV 4850 Ampere Drive Reno, NV 89502
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 233152811